Volume 185, Issue 2, Pages (February 2011)

Slides:

Advertisements

Similar presentations

Development and Clinical Validation of a Real-Time PCR Assay for PITX2 DNA Methylation to Predict Prostate-Specific Antigen Recurrence in Prostate Cancer.

Advertisements

Volume 188, Issue 4, Pages (October 2012)

Volume 187, Issue 6, Pages (June 2012)

Volume 62, Issue 3, Pages (September 2012)

Interpreting Statistics in the Urological Literature

Volume 155, Issue 3, Pages (March 1996)

Volume 165, Issue 5, Pages (May 2001)

MP60-03 PROSTATE CANCER IN THE ELDERLY

Volume 187, Issue 6, Pages (June 2012)

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach,

Volume 179, Issue 2, Pages (February 2008)

Volume 195, Issue 4, Pages e13-e14 (April 2016)

Volume 12, Issue 11, Pages (October 2011)

Volume 195, Issue 5, Pages (May 2016)

2327 PROSTATE CANCER STAGE, GRADE AND POSITIVE MARGIN RATE IN MEN WITH PSA ≥ 1 ng/ml UNDERGOING RADICAL PROSTATECTOMY: POPULATION DATA ANALYSIS Sergey.

KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate- Specific Antigen-Relapse Following Radical Prostatectomy Johannes Stein,

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis K.

The Male Factor in Fertility and Infertility. II

Volume 4, Issue 5, Pages (September 2017)

Volume 52, Issue 5, Pages (November 2007)

Volume 199, Issue 2, Pages (February 2018)

Volume 199, Issue 1, Pages (January 2018)

Studies on the Growth of Cells

Bladder Lymphoma The Journal of Urology

Volume 199, Issue 4, Pages e143-e144 (April 2018)

Volume 186, Issue 5, Pages (November 2011)

Volume 199, Issue 1, (January 2018)

Seminal Vesicle Invasion by Adenocarcinoma of the Prostate

Volume 42, Issue 4, Pages (October 2002)

Volume 199, Issue 6, Pages (June 2018)

Oncocytoma of the Kidney

Mark H. Ebell, Taylor Radke, Jack Gardner The Journal of Urology

Paratesticular Serous Papillary Borderline Tumor

Volume 59, Issue 2, Pages (February 2011)

Volume 189, Issue 1, Pages (January 2013)

Regional Variation in Quality of Prostate Cancer Care

Volume 197, Issue 2, Pages S189-S197 (February 2017)

Volume 199, Issue 1, Pages (January 2018)

Pseudohyperplastic Adenocarcinoma of the Prostate

Volume 193, Issue 4, Pages e688-e689 (April 2015)

Chun Chieh Lin, PhD, MBA, Matthew P

Volume 53, Issue 4, Pages (April 2008)

Volume 184, Issue 4, Pages (October 2010)

Volume 199, Issue 4, Pages (April 2018)

Development and Clinical Validation of a Real-Time PCR Assay for PITX2 DNA Methylation to Predict Prostate-Specific Antigen Recurrence in Prostate Cancer.

Volume 199, Issue 1, Pages (January 2018)

Volume 53, Issue 2, Pages (February 2008)

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Model-Free Linkage Analysis with Covariates Confirms Linkage of Prostate Cancer to Chromosomes 1 and 4 Katrina A.B. Goddard, John S. Witte, Brian K.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Volume 58, Issue 1, Pages (July 2010)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach,

Yuqiu Jiang, Graham Casey, Ian C

Molecular Subtypes of Non-muscle Invasive Bladder Cancer

Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence Xiaoyu Qu, Claudio Jeldres, Lena Glaskova, Cynthia.

Development of a Diagnostic Microarray Assay to Assess the Risk of Recurrence of Prostate Cancer Based on PITX2 DNA Methylation Philipp Schatz, Dimo.

Volume 74, Issue 6, Pages (December 2018)

Support Your Specialty

Model-Free Linkage Analysis with Covariates Confirms Linkage of Prostate Cancer to Chromosomes 1 and 4 Katrina A.B. Goddard, John S. Witte, Brian K.

MiRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome Nadine Ratert, Hellmuth-Alexander Meyer, Monika Jung, Poline.

Volume 54, Issue 1, Pages (July 2008)

Forced Expiratory Volume in One Second as a Prognostic Factor in Advanced Non- small Cell Lung Cancer Jin Hwa Lee, MD, PhD, Eun Mi Song, MD, Yun Su Sim,

Volume 50, Issue 6, Pages (December 2006)

Fernando P. Secin, Fernando J. Bianco, Nicholas T

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer Alessandro Brunelli, MD, Michele.

Surgical outcomes after cardiac surgery in liver transplant recipients

Padmanee Sharma, James P. Allison Cell

Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases Benjamin M. Robinson, BSc, MBBS, Catherine Kennedy,

Presentation transcript:

Volume 185, Issue 2, Pages 706-711 (February 2011) Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical Progression Florian Jentzmik, Carsten Stephan, Michael Lein, Kurt Miller, Beate Kamlage, Bianca Bethan, Glen Kristiansen, Klaus Jung The Journal of Urology Volume 185, Issue 2, Pages 706-711 (February 2011) DOI: 10.1016/j.juro.2010.09.077 Copyright © 2011 American Urological Association Education and Research, Inc. Terms and Conditions

Figure 1 Sarcosine in 92 matched malignant and nonmalignant prostatectomy samples (A), and in malignant samples categorized by pathological stage pT2 vs pT3 (B), and by prostatectomy based Gleason score less than 7 vs 7 or greater (C). Differences were tested by the Wilcoxon matched pairs (A) and Mann-Whitney U (B and C) tests. The Journal of Urology 2011 185, 706-711DOI: (10.1016/j.juro.2010.09.077) Copyright © 2011 American Urological Association Education and Research, Inc. Terms and Conditions

Figure 2 Kaplan-Meier curves were calculated for biochemical recurrence-free time after surgery by pathological tumor stage pT2 vs pT3 (A), tumor grade with Gleason score less than 7, 7 and greater than 7 (B), and sarcosine less vs greater than median 0.407 (C). Differences were tested by log rank test. Blue curve indicates pT2a to pT2b (A), Gleason score less than 7 (B) and less than median (C). Green curve indicates pT3a to pT3b (A), Gleason score 7 (B) and median (C). Red curve indicates Gleason score greater than 7 (C). Tick marks indicate censored. The Journal of Urology 2011 185, 706-711DOI: (10.1016/j.juro.2010.09.077) Copyright © 2011 American Urological Association Education and Research, Inc. Terms and Conditions